trending Market Intelligence /marketintelligence/en/news-insights/trending/whutpzd9qsctjkuw7ktu3w2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Catalyst Biosciences closes $115M common stock offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Catalyst Biosciences closes $115M common stock offering

Catalyst Biosciences Inc. closed its underwritten public offering of 3,382,352 common shares at $34 apiece with gross proceeds of about $115 million.

The shares include the full exercise of the underwriters' option to buy an additional 441,176 shares.

JonesTrading Institutional Services LLC acted as sole book-running manager and Ladenburg Thalmann & Co. Inc. acted as joint book runner.

LifeSci Capital LLC acted as lead manager and B. Riley FBR Inc. acted as co-manager of the offering.